Macquarie University
About
Macquarie University supports a comprehensive array of medical imaging, specialising in neurodegenerative and neurocognitive, respiratory, cardiac and nuclear medicine as well as PET, and has significant experience with clinician led as well as pharma-sponsored clinical trials. Macquarie boasts a fully integrated radiology and molecular imaging department with a full medical imaging suite including multiple CT, MRI, PET, located within Macquarie University Hospital (MUH). Also on the Macquarie University campus are the Magnetoencephalography (MEG) and related electrophysiological recording technologies, located within the Australian Hearing Hub.
As part of MQ Health, the Macquarie University Node has access to research-driven clinicians, in addition to large and varied patient cohorts. Our collaboration with the Macquarie University Clinical Trials Unit enables a translational research pathway from basic human research through phase I to phase IV clinical trials. Macquarie’s integrated design allows for multi-modality scheduling for time critical studies. Co-location of the only child MEG in the Southern Hemisphere and a prototype system developed for use with hearing aid devices within the Australian Hearing Hub provides academic and translational research capabilities.
Locations
Macquarie Medical Imaging
Ground Floor, 3 Technology Place
Macquarie University NSW 2109
The Australian Hearing Hub
16 University Avenue
Macquarie University NSW 2109
Contact
Latest news
An Australian first: next-generation neuroimaging scanner launched at University of Melbourne
08 May 2026
Announcement: NIF’s 2026 Annual Scientific Meeting
05 February 2026
First dementia treatment drug approved for Australia, supported by NIF capacity
16 June 2025
New molecular-imaging network launched to benefit cancer, dementia imaging and new radiopharmaceuticals
26 May 2025